Clinical Trial Update: Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Early Stage, HER2-Positive or Triple Negative Breast Cancer [NA]

View source ↗

Summary

Completed clinical trial evaluating an implantable microdevice to test in vivo drug sensitivity in patients with early-stage HER2-positive or triple-negative br…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | NA | Status: COMPLETED | Results posted: 2025-08-22